Search Results - "Lundon, Dara"

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer by Gaglani, Simita, Gonzalez-Kozlova, Edgar, Lundon, Dara J, Tewari, Ashutosh K, Dogra, Navneet, Kyprianou, Natasha

“…Extracellular vesicles (EVs) have brought great momentum to the non-invasive liquid biopsy procedure for the detection, characterization, and monitoring of…”
Get full text

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer by Chakravarty, Dimple, Nair, Sujit S., Hammouda, Nada, Ratnani, Parita, Gharib, Yasmine, Wagaskar, Vinayak, Mohamed, Nihal, Lundon, Dara, Dovey, Zachary, Kyprianou, Natasha, Tewari, Ashutosh K.

“…The recent outbreak of infections and the pandemic caused by SARS-CoV-2 represent one of the most severe threats to human health in more than a century…”
Get full text

Reverse Trendelenburg Positioning Minimizes Stone Retropulsion During Ureteroscopic Laser Lithotripsy: A Prospective Randomized Study by Anastos, Harry, Yaghoubian, Alan J, Khusid, Johnathan A, Chandhoke, Ryan A, Lundon, Dara J, Sadiq, Areeba S, Bamberger, Jacob N, Gallante, Blair, Shimonov, Roman, Atallah, William M, Gupta, Mantu

“…Retropulsion of stone fragments during ureteroscopic laser lithotripsy (URSLL) remains a challenge for urologists and is associated with increased operative…”
Get more information

Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer by Lundon, Dara J., Dovey, Zachary, Tewari, Ashutosh K.

Get full text

Prostate cancer in transgender women: considerations for screening, diagnosis and management by Crowley, Fionnuala, Mihalopoulos, Meredith, Gaglani, Simita, Tewari, Ashutosh K., Tsao, Che-Kai, Djordjevic, Miroslav, Kyprianou, Natasha, Purohit, Rajveer S., Lundon, Dara J.

“…Transgender individuals represent 0.55% of the US population, equivalent to 1.4 million transgender adults. In transgender women, feminisation can include a…”
Get full text

Does Gender Matter in Academic Surgery? Author and Mentor Gender Impact Publication Citations in Surgical Research by Shukla, Devki C., Simma-Chiang, Vannita, Kyprianou, Natasha, Tewari, Ashutosh K., Lundon, Dara J.

“…To examine female author representation within publications in the field of urology from the United States from 2000-2019. All 25,787 articles with a U.S…”
Get full text

Prostate cancer risk prediction and the persistence of uncertainty by Lundon, Dara J.

Get full text

Displacement of Lower Pole Stones During Retrograde Intrarenal Surgery Improves Stone-free Status: A Prospective Randomized Controlled Trial by Yaghoubian, Alan J, Anastos, Harry, Khusid, Johnathan A, Shimonov, Roman, Lundon, Dara J, Khargi, Raymond, Gallante, Blair, Gassmann, Kyra, Bamberger, Jacob N, Chandhoke, Ryan, Zampini, Anna, Atallah, William, Gupta, Mantu

“…Lower pole renal stones are associated with the lowest stone-free status of any location in the urinary tract during retrograde intrarenal surgery. Prior work…”
Get full text

Telehealth in Urology by Lundon MBA, Dara

“…Offering significant benefits to both healthcare providers and patients, telehealth is a key component in the future of urology and patient care. Telehealth in…”
Get full text

Selecting an Endourology Society Fellowship Program: The Candidates' Perspectives by Yaghoubian, Alan J, Khargi, Raymond, Khusid, Johnathan A, Ricapito, Anna, Gallante, Blair, Lundon, Dara J, Connors, Christopher, Shimonov, Roman, Atallah, William M, Gupta, Mantu

“…Understanding the factors that influence the decision of urology residents to pursue an Endourology Society (ES) fellowship and the criteria used by applicants…”
Get more information

European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi‐institutional study by Foley, Robert W., Maweni, Robert M., Gorman, Laura, Murphy, Keefe, Lundon, Dara J., Durkan, Garrett, Power, Richard, O'Brien, Frank, O'Malley, Kieran J., Galvin, David J., Brendan Murphy, T., William Watson, R.

“…Objective To analyse the performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPT‐RC) and two iterations of the European Randomised Study of…”
Get full text

A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey by Caballero, Carmela, Lundon, Dara J., Vasileva-Slaveva, Mariela, Montagna, Giacomo, Bonci, Eduard-Alexandru, Brandl, Andreas, Smith, Henry, Kok, Johnn Henry Herrera, Holmberg, Carl-Jacob, Sayyed, Raza, Santrac, Nada, Suppan, Ina, Kaul, Pallvi, Vassos, Nikolaos, Lorenzon, Laura, Murphy, Marlena, Ceelen, Wim, de Azambuja, Evandro, McIntosh, Stuart A., Rubio, Isabel T.

“…Surgical de-escalation aims to reduce morbidity without compromising oncological outcomes. Trials to de-escalate breast cancer (BC) surgery among exceptional…”
Get full text

Improving multivariable prostate cancer risk assessment using the Prostate Health Index by Foley, Robert W., Gorman, Laura, Sharifi, Neda, Murphy, Keefe, Moore, Helen, Tuzova, Alexandra V., Perry, Antoinette S., Murphy, T. Brendan, Lundon, Dara J., Watson, R. William G.

“…Objectives To analyse the clinical utility of a prediction model incorporating both clinical information and a novel biomarker, p2PSA, in order to inform the…”
Get full text

Do Infection-Associated Stone Subtypes Behave the Same Clinically? A Retrospective Bicenter Study by Popovtzer, Baruch, Khusid, Johnathan A, Bamberger, Jacob N, Lundon, Dara J, Gallante, Blair, Sadiq, Areeba S, Atallah, William M, Lifshitz, David, Gupta, Mantu

“…Infection-associated renal stones are commonly composed of magnesium-ammonium-phosphate (MAP) and carbonate apatite (CA). The clinical implications of these…”
Get more information

Criteria Used by Endourology Society Fellowship Program Directors for the Selection and Evaluation of Fellows by Gupta, Kavita, Khusid, Johnathan A, Lundon, Dara J, Gallante, Blair, Sadiq, Areeba S, Atallah, William M, Gupta, Mantu

“…An understanding of which trainee factors Endourology Society (ES) fellowship program directors (PDs) value may help urology residents optimize their…”
Get more information

Simultaneous injection of 18F-BF3- Cy3-ACUPA and non-radioactive Cy7-ACUPA probes: a promising pre-biopsy PET and ex vivo fluorescence imaging approach to evaluate prostate cancer by Aras, Omer, Demirdag, Cetin, Kommidi, Harikrishna, Pavlova, Ina, Boyko, Vitaly, Lundon, Dara J., Ting, Richard, Tewari, Ashutosh, Akin, Oguz, Sayman, Haluk B

Get full text

Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer by Buac, Neil P., Khusid, Johnathan A., Sturgis, Morgan R., Gupta, Mantu, Lundon, Dara J., Chow, Alexander K., Becerra, Adan Z.

“…•Among patients with muscle invasive bladder cancer, those who identified as Black and Hispanic were more likely to have treatment delays compared to those who…”
Get full text

Prostate MRI percentage tumor involvement or “PI‐RADS percent” as a predictor of adverse surgical pathology by Ratnani, Parita, Dovey, Zach, Parekh, Sneha, Sobotka, Stanislaw, Shukla, Devki, Davis, Avery, Roshandel, Reza, Wagaskar, Vinayak, Jambor, Ivan, Lundon, Dara J., Wiklund, Peter, Kyprianou, Natasha, Menon, Mani, Tewari, Ash

“…Background This study assesses magnetic resonance imaging (MRI) prostate % tumor involvement or “PI‐RADs percent” as a predictor of adverse pathology (AP)…”
Get full text

A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort by Jalali, Amirhossein, Foley, Robert W, Maweni, Robert M, Murphy, Keefe, Lundon, Dara J, Lynch, Thomas, Power, Richard, O'Brien, Frank, O'Malley, Kieran J, Galvin, David J, Durkan, Garrett C, Murphy, T Brendan, Watson, R William

“…Prostate cancer (PCa) represents a significant healthcare problem. The critical clinical question is the need for a biopsy. Accurate risk stratification of…”
Get full text

Social Determinants Predict Outcomes in Data From a Multi-Ethnic Cohort of 20,899 Patients Investigated for COVID-19 by Lundon, Dara J, Mohamed, Nihal, Lantz, Anna, Goltz, Heather H, Kelly, Brian D, Tewari, Ashutosh K

“…The COVID-19 pandemic exploits existing inequalities in social determinants of health (SDOH) in disease burden and access to healthcare. Few studies have…”
Get full text